licensing agreement
Exact Sciences Projects up to $475M in Q4 Revenues, Acquires Testing Lab, Inks Licensing Deal
The approximately 2 percent increase over Q4 2020 results beat analysts' expectations, and the acquisition news heralds market expansion into hereditary cancer testing.
Mainz Biomed Licenses mRNA Biomarkers for Colorectal Cancer
Mainz said it will potentially integrate the biomarkers into its ColoAlert detection test for colorectal cancer.
Baylor Genetics, SRL Ink Clinical Sequencing Tech Transfer Agreement
Under the agreement, Baylor Genetics will transfer its clinical-grade whole-genome and whole-exome sequencing technology to SRL beginning in 2022.
EpiCypher Licenses Chromatin Profiling Technologies From Fred Hutchinson Cancer Center
The technologies, licensed co-exclusively, can be used to study histone post-translational modifications and chromatin-associated proteins.
RNA Disease Diagnostics Licenses RNA Lateral Flow Tech for At-Home SARS-CoV-2 Test
The company said the technology does not require nucleic acid amplification or isolation and can detect SARS-CoV-2 as effectively as PCR-based methods.
Jul 27, 2021
ERS Genomics Licenses CRISPR IP to Japan SLC
Jul 1, 2021
ERS Genomics Licenses CRISPR IP to Nippon Gene
Jun 7, 2021
ERS Genomics Licenses CRISPR IP to GenOway
Apr 19, 2021
ERS Genomics Licenses CRISPR Patents to Nuvisan
Mar 10, 2021